research
aim
studi
effect
interferon
ifn
base
drug
behavior
immunolog
paramet
calv
specif
prevent
associ
infect
object
research
black
motley
cow
calv
birth
month
life
serum
colostrum
sampl
screen
antibodi
rotaviru
diarrhea
coronaviru
use
serolog
method
test
perform
vaccin
day
calv
day
calv
calv
colostrum
sampl
taken
first
milk
yield
serum
sampl
calv
drawn
colostrum
feed
well
day
month
age
measur
level
immunoglobulin
g
addit
serum
sampl
collect
calv
day
birth
result
give
pregnant
cow
ifnbas
drug
dose
mlkg
h
vaccin
result
develop
accumul
antibodi
rotaviru
coronaviru
viral
diarrhea
vd
colostrum
titer
log
log
log
respect
indic
increas
antigen
activ
multival
vaccin
conclus
ifnbas
drug
enhanc
protect
effect
vaccin
associ
infect
newborn
calv
stimul
rise
titer
antibodi
rotaviru
coronaviru
vd
mucos
diseas
complex
well
increas
immunoglobulin
g
effect
protect
infecti
diseas
involv
specif
prevent
ie
vaccin
howev
could
sometim
ineffect
problem
solv
use
immunestimul
drug
immunestimul
caus
chang
activ
humor
cellular
compon
immun
system
therebi
strengthen
immun
respons
end
promis
group
immunestimul
agent
includ
base
natur
interferon
ifn
term
veterinari
medicin
ifn
interest
due
antivir
antiinflammatori
properti
ifn
claim
role
therapeut
prevent
treatment
viral
bacteri
mix
bacterialvir
infect
moreov
highli
effect
immunemodul
antistress
agent
modifi
action
treatment
medic
exampl
antibiot
ten
time
amplifi
antibacteri
effect
neutral
neg
impact
immun
system
success
product
ifninduc
strain
sophist
method
refold
purifi
protein
new
uniqu
formul
result
wide
rang
monoand
multicompon
veterinari
prepar
address
differ
issu
veterinari
scienc
main
distinguish
featur
develop
drug
speci
specif
correspond
speci
specif
ifn
includ
composit
uniqu
prepar
activ
principl
protect
protein
complet
ident
anim
one
thu
anim
treat
foreign
substanc
protect
agent
simpli
increas
concentr
bodi
induc
ifnbas
prepar
right
time
total
three
group
veterinari
drug
monocompon
iii
multicompon
prepar
ifn
complex
vitamin
e
c
activ
ingredi
optimum
physiolog
ratio
antivir
effect
ifn
appear
insid
cell
associ
suppress
viru
reproduct
ifn
act
extracellular
virus
adsorpt
ifn
activ
insid
cell
produc
must
secret
reabsorb
cell
bind
correspond
receptor
cell
membran
differ
type
protein
receptor
bind
cell
receptor
complex
ifn
diffus
aggreg
cell
surfac
undergo
endocytosi
occur
h
get
insid
cell
activ
process
result
antivir
state
determin
differ
effect
metabol
name
take
place
product
differ
intracellular
protein
oligoadenyl
synthetas
protein
kinas
import
wellstudi
enzym
system
ultim
induc
spread
reproduct
viru
vivo
inactiv
earli
viral
mrna
inhibit
synthesi
viral
protein
cell
ribosom
viral
nucleic
acid
replic
ifn
induc
endogen
ifn
activ
absorpt
monocyt
tissu
macrophag
higher
ingest
rate
relat
increas
activ
macrophag
element
accompani
growth
number
phagocyt
cell
diseas
prevent
treatment
help
ifn
develop
two
direct
introduct
readymad
form
ifn
exogen
interferon
stimul
ifn
product
cell
bodi
influenc
induc
endogen
interferon
base
preced
search
use
ifn
induc
wide
rang
antivir
immunemodul
effect
promis
necessari
direct
immun
pharmacolog
meanwhil
sever
main
direct
use
ifn
outlin
veterinari
practic
use
exogen
ifn
use
endogen
ifn
induc
combin
use
ifn
chemotherapeut
drug
vaccin
research
aim
studi
effect
ifnbas
drug
calf
immunolog
paramet
specif
prophylaxi
associ
infect
studi
conduct
ethic
principl
approv
anim
experi
ethic
committe
feder
state
budgetari
educ
institut
higher
profession
educ
bashkir
state
agrarian
univers
protocol
research
carri
livestock
farm
chishminski
district
republ
bashkortostan
russian
feder
object
research
black
motley
cow
calv
birth
month
life
anim
research
select
analog
approach
fed
kept
condit
anim
research
select
ident
age
live
weight
calv
two
month
age
receiv
daili
diet
anim
room
meet
zoohygien
requir
keep
cattl
work
base
inactiv
combin
vaccin
combovac
infecti
rhinotrach
viral
diarrhea
vd
respiratori
syncyti
rotaviru
coronaviru
diseas
calv
scientif
product
commun
narvak
moscow
ifn
bovin
recombin
ibr
scientif
product
center
belagrogen
llc
belorussia
immun
scientif
product
center
belagrogen
llc
belorussia
mother
cow
first
experiment
group
h
vaccin
inject
immunostimul
ibr
dose
mlkg
bodi
weight
vaccin
carri
twice
accord
instruct
inject
subcutan
neck
dose
ml
day
calv
st
time
day
calv
nd
time
anim
second
experiment
group
vaccin
administ
accord
scheme
fortyeight
hour
vaccin
immunomodul
immun
inject
dose
ml
per
anim
control
cow
pregnant
vaccin
one
given
immunostimul
newborn
calv
divid
nine
group
follow
divis
mother
cow
first
scientif
experi
five
anim
calv
group
cow
divid
three
group
first
group
calv
obtain
cow
first
control
group
drug
use
control
second
stage
research
furthermor
immunostimul
drug
use
fourth
seventh
experiment
group
calv
obtain
mother
cow
second
third
experiment
group
calv
second
fifth
eighth
experiment
group
use
ibr
immunostimul
dose
kg
bodi
weight
st
day
birth
twice
interv
h
calv
third
sixth
ninth
experiment
group
inject
prepar
immun
dose
ml
per
anim
vaccin
mother
cow
combovac
vaccin
carri
twice
accord
instruct
inject
subcutan
neck
area
dose
ml
day
calv
st
time
day
calv
nd
time
vaccin
obtain
calv
combovac
vaccin
associ
infect
carri
twice
one
millilit
vaccin
avail
inject
neck
area
subcutan
age
day
interv
day
serum
colostrum
sampl
mother
cow
assay
antibodi
rotaviru
diarrhea
coronaviru
use
serolog
method
test
carri
vaccin
day
calv
day
calv
calv
colostrum
sampl
taken
first
milk
yield
assess
colostr
immun
calv
born
vaccin
cow
serum
sampl
drawn
colostrum
feed
well
day
month
age
serum
colostrum
sampl
control
experiment
anim
assay
antibodi
rotaviru
vd
enzymelink
immunosorb
assay
coronaviru
hemagglutin
inhibit
assay
total
amount
immunoglobulin
g
blood
sera
anim
day
birth
determin
quantit
method
radial
immunodiffus
number
immunoglobulin
mgml
determin
calibr
curv
reflect
relationship
logarithm
concentr
immunoglobulin
serum
diamet
precipit
ring
experiment
data
process
statist
analysi
packag
microsoft
excel
signific
differ
group
evalu
use
student
ttest
vaccin
signific
increas
rotaviru
antibodi
titer
blood
serum
pregnant
cow
compar
initi
amount
vaccin
initi
titer
antibodi
vaccin
time
calv
increas
anim
third
group
amount
p
control
group
antibodi
titer
cow
calv
log
anim
second
experiment
group
increas
postvaccin
antibodi
calv
log
p
colostrum
first
milk
yield
calv
cow
control
group
rotaviru
antibodi
amount
log
second
experiment
group
indic
exceed
control
log
third
experiment
group
titer
colostrum
antibodi
experiment
cow
exceed
control
valu
log
first
control
group
number
coronaviru
antibodi
chang
significantli
experi
slightli
decreas
time
calv
third
experiment
group
highest
increas
postvaccin
titer
higher
baselin
serum
colostrum
sampl
control
group
nonimmunostimul
cow
prove
coronaviru
antibodi
present
anim
calv
nd
day
level
antibodi
decreas
time
small
amount
found
milk
rd
day
lactat
anim
anim
second
third
group
coronaviru
antibodi
titer
p
day
calv
p
day
lactat
respect
th
th
day
antibodi
indic
antigen
detect
titer
titer
coronaviru
antibodi
gradual
decreas
th
day
lactat
detect
vaccin
titer
antibodi
vd
group
cow
rang
log
first
control
group
indic
chang
significantli
first
second
vaccin
decreas
time
calv
group
anim
use
ibr
immunostimul
second
group
averag
titer
vd
antibodi
calv
exceed
prevaccin
antibodi
titer
control
group
averag
titer
vd
antibodi
calv
exceed
prevaccin
titer
third
group
titer
humor
antibodi
immun
immun
increas
differ
antibodi
titer
calv
control
third
group
p
titer
colostrum
secretori
antibodi
vd
second
experiment
group
exceed
control
valu
log
third
experiment
group
surpass
control
valu
log
colostrum
intak
calv
rotaviru
antibodi
blood
serum
one
see
end
st
week
birth
rotaviru
antibodi
reach
maximum
valu
month
birth
level
antibodi
slightli
decreas
group
calv
avail
dynam
immunoglobulin
serum
calv
nd
month
birth
titer
humor
antibodi
increas
experiment
group
decreas
control
one
typic
valu
rotavirusspecif
antibodi
titer
experiment
group
significantli
exceed
control
group
maximum
differ
indic
experiment
control
group
record
calv
sixth
ninth
experiment
group
colostrum
intak
calv
coronaviru
antibodi
blood
serum
dynam
serum
antibodi
calv
follow
antibodi
titer
reach
maximum
valu
end
st
week
anim
life
highest
level
indic
calv
sixth
eighth
ninth
group
valu
gradual
decreas
end
observ
period
month
calv
control
experiment
group
antibodi
vd
absent
colostrum
administr
end
st
week
life
titer
humor
antibodi
experiment
group
calv
reach
maximum
valu
highest
deviat
valu
control
group
record
calv
obtain
mother
cow
immunostimul
vaccin
pregnanc
calv
also
given
immunostimul
birth
eighth
ninth
experiment
group
indic
maximum
mark
exceed
control
log
respect
subsequ
antibodi
titer
anim
group
gradual
decreas
experiment
one
steadili
exceed
control
indic
danish
scholar
also
found
correl
ifn
increas
antibodi
titer
studi
devot
poultri
scientist
conduct
studi
farm
anim
prevent
treat
viral
bacteri
infect
use
ifn
prove
effect
posit
dynam
immunoglobulin
monitor
day
period
studi
content
immunoglobulin
g
blood
serum
calv
control
group
lower
similar
indic
calv
experiment
group
maximum
differ
indic
control
found
anim
sixth
ninth
group
henc
th
day
experi
sixth
group
content
immunoglobulin
g
higher
control
mgml
ninth
mgml
respect
howev
th
day
experi
decreas
number
serum
immunoglobulin
g
observ
studi
group
calv
maximum
decreas
record
control
group
sixth
ninth
group
calv
smallest
decreas
immunoglobulin
g
record
thu
research
found
dose
pregnant
cow
ifnbas
drug
mlkg
h
vaccin
contribut
accumul
rotaviru
coronaviru
vd
antibodi
colostrum
titer
log
log
log
respect
indic
increas
antigen
activ
multival
vaccin
ifnbas
drug
enhanc
protect
effect
vaccin
rotaviru
coronaviru
enter
vd
mucos
diseas
newborn
calv
achiev
increas
titer
associ
antibodi
immunoglobulin
g
sum
use
ifnbas
drug
vaccin
increas
effici
vaccin
enhanc
colostr
immun
help
improv
surviv
young
anim
